These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Application of Fluorescent Purinoceptor Antagonists for Bioluminescence Resonance Energy Transfer Assays and Fluorescent Microscopy. Soave M; Goulding J; Markus R; Hill SJ; Stoddart LA Methods Mol Biol; 2020; 2041():163-181. PubMed ID: 31646488 [TBL] [Abstract][Full Text] [Related]
3. Recent developments in adenosine receptor ligands and their potential as novel drugs. Müller CE; Jacobson KA Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259 [TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
5. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). Jacobson KA Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524 [TBL] [Abstract][Full Text] [Related]
7. Adenosine receptor ligands: where are we, and where are we going? Tuccinardi T; Martinelli A Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944 [No Abstract] [Full Text] [Related]
8. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms. Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139 [TBL] [Abstract][Full Text] [Related]
9. Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. Ciruela F; Fernández-Dueñas V; Jacobson KA Neuropharmacology; 2015 Nov; 98():58-67. PubMed ID: 25890205 [TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode. Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875 [TBL] [Abstract][Full Text] [Related]
12. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives. Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265 [TBL] [Abstract][Full Text] [Related]
13. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands. Baker JG; Middleton R; Adams L; May LT; Briddon SJ; Kellam B; Hill SJ Br J Pharmacol; 2010 Feb; 159(4):772-86. PubMed ID: 20105183 [TBL] [Abstract][Full Text] [Related]
14. Ribose modified nucleosides and nucleotides as ligands for purine receptors. Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046 [TBL] [Abstract][Full Text] [Related]
15. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers. Vernall AJ; Stoddart LA; Briddon SJ; Ng HW; Laughton CA; Doughty SW; Hill SJ; Kellam B Org Biomol Chem; 2013 Sep; 11(34):5673-82. PubMed ID: 23881285 [TBL] [Abstract][Full Text] [Related]
16. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926 [TBL] [Abstract][Full Text] [Related]
17. Novel Alexa Fluor-488 labeled antagonist of the A(2A) adenosine receptor: Application to a fluorescence polarization-based receptor binding assay. Kecskés M; Kumar TS; Yoo L; Gao ZG; Jacobson KA Biochem Pharmacol; 2010 Aug; 80(4):506-11. PubMed ID: 20438717 [TBL] [Abstract][Full Text] [Related]
18. 7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors. Macchia M; Salvetti F; Bertini S; Di Bussolo V; Gattuso L; Gesi M; Hamdan M; Klotz KN; Laragione T; Lucacchini A; Minutolo F; Nencetti S; Papi C; Tuscano D; Martini C Bioorg Med Chem Lett; 2001 Dec; 11(23):3023-6. PubMed ID: 11714602 [TBL] [Abstract][Full Text] [Related]
19. Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors. Deb PK Curr Pharm Des; 2019; 25(7):747-749. PubMed ID: 31232230 [No Abstract] [Full Text] [Related]
20. Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists. Kolb P; Phan K; Gao ZG; Marko AC; Sali A; Jacobson KA PLoS One; 2012; 7(11):e49910. PubMed ID: 23185482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]